(2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one
TL;DR: (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one (CAS 494200-63-4) is a chemical compound with molecular formula C29H29NO6 and molecular weight 487.20 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
(E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one
Also Known As: (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one, (2E)-2-benzoxazol-2-yl-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en- 1-one, 2-benzooxazol-2-yl-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one, (E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one, (E)-2-(benzo[d]oxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one
| Molecular Formula | C29H29NO6 |
|---|---|
| Molecular Weight | 487.20 g/mol |
| LogP | 6.456 |
| Topological Polar Surface Area | 80.02 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 11 |
| Exact Mass | 487.1995 |
| Heavy Atoms | 36 |
| Complexity | 1337.5508 |
Chemical Identifiers
| CAS Number | 494200-63-4 |
|---|---|
| SMILES | CCCCOC1=CC=C(C=C1)C(=O)/C(=C/C2=CC(=C(C=C2OC)OC)OC)/C3=NC4=CC=CC=C4O3 |
Product Overview
(2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one (CAS 494200-63-4), with molecular formula C29H29NO6 and molecular weight 487.20 g/mol. IUPAC: (E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one.
Chemical Property Profile of (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one
Property Insights of (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one
The XLogP value of 6.456 indicates that (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 80.02 Ų falls within the moderate polarity range, balancing permeability and solubility for (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one. Following Lipinski's Rule of Five, (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one has 0 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), which may warrant consideration for formulation optimization.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one?
The CAS number of (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one is 494200-63-4.
What is the molecular formula of (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one?
The molecular formula of (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one is C29H29NO6.
What is the molecular weight of (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one?
The molecular weight of (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one is 487.20 g/mol.
Where can I buy (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one?
You can request a quote for (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one?
Yes, KEHONG BIO provides custom synthesis services for (2E)-2-(1,3-benzoxazol-2-yl)-1-(4-butoxyphenyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.